BASE - Couchbase Inc

https://www.couchbase.com

Buy Momentum: Bearish

Recent News

Bullish

Is Couchbase ( BASE ) Stock Outpacing Its Computer and Technology Peers This Year?

Zacks Commentary • 6 days, 3 hours ago • score: 0.47

Here is how Couchbase, Inc. (BASE) and Lyft (LYFT) have performed compared to their sector so far this year.

Neutral

Couchbase, Inc. ( BASE ) Reports Q2 Loss, Beats Revenue Estimates

Zacks Commentary • 1 week, 4 days ago • score: 0.14

Couchbase (BASE) delivered earnings and revenue surprises of +66.67% and +5.17%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Bullish

Couchbase Posts 12% Revenue Gain in Q2

Motley Fool • 1 week, 4 days ago • score: 0.21

Couchbase ( NASDAQ:BASE ) is an enterprise data platform company focused on powering mission-critical applications with its NoSQL and cloud database solutions. On September 3, 2025, it reported results for the second quarter of fiscal 2026.

Bullish

COUCHBASE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Couchbase, Inc. - BASE - Couchbase ( NASDAQ:BASE )

Benzinga • 3 weeks, 5 days ago • score: 0.22

NEW YORK and NEW ORLEANS, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ( "KSF" ) are investigating the proposed sale of Couchbase, Inc. BASE to Haveli Investments.

Bullish

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: International Money Express, Inc. ( Nasdaq - IMXI ) , MeridianLink, Inc. ( NYSE - MLNK ) , Monroe Capital Corporation ( Nasdaq - MRCC ) , Couchbase, Inc. ( Nasdaq - BASE )

Benzinga • 1 month ago • score: 0.24

BALA CYNWYD, Pa., Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.

Bullish

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company ( Nasdaq - STAA ) , Y-mAbs Therapeutics, Inc. ( Nasdaq - YMAB ) , Couchbase, Inc. ( Nasdaq - BASE ) , Core Scientific, Inc. ( Nasdaq - CORZ )

Benzinga • 1 month, 1 week ago • score: 0.22

BALA CYNWYD, Pa., Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

None

52W High

$25.16

52W Low

$12.78

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.93

Valuation

As of 2025-07-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-9.29

EV/Revenue (<3 favorable)

5.51

P/S (TTM) (<3 favorable)

6.12

P/B (<3 favorable)

10.89

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.05%

Institutions (25–75% balanced)

98.09%

Shares Outstanding

55,254,000

Float

42,642,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-07-31 (Overview)

Revenue (TTM)

220,639,000

Gross Profit (TTM)

193,628,000

EPS (TTM)

-1.41

Profit Margin (>10% good)

-0.34%

Operating Margin (TTM) (higher better)

-0.44%

ROE (TTM) (>15% strong)

-0.60%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.12

Momentum

Bearish momentum

Value

0.0892

0.0981

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025